Key Insights

Highlights

Success Rate

91% trial completion (above average)

Research Maturity

71 completed trials (31% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.0%

7 terminated out of 231 trials

Success Rate

91.0%

+4.5% vs benchmark

Late-Stage Pipeline

9%

21 trials in Phase 3/4

Results Transparency

3%

2 of 71 completed with results

Key Signals

2 with results91% success

Data Visualizations

Phase Distribution

182Total
Not Applicable (70)
Early P 1 (1)
P 1 (19)
P 2 (71)
P 3 (16)
P 4 (5)

Trial Status

Completed71
Unknown55
Recruiting53
Not Yet Recruiting34
Terminated7
Enrolling By Invitation5

Trial Success Rate

91.0%

Benchmark: 86.5%

Based on 71 completed trials

Clinical Trials (231)

Showing 20 of 20 trials
NCT07738159Phase 2Not Yet Recruiting

Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary Neuroendocrine Carcinoma

NCT04889924Not ApplicableRecruiting

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

NCT07731477Not ApplicableRecruiting

The Effect of a Virtual Reality-Based Mindfulness Intervention on Anxiety, Comfort, Sleep, and Fatigue in Breast Cancer Patients Undergoing Chemotherapy

NCT07713381Not ApplicableNot Yet Recruiting

Effect of AI-Assisted Expressive Writing on Anxiety, Emotional Distress, and Quality of Life Among Patients Receiving Chemotherapy

NCT07699913Not Yet Recruiting

Quality of Life of Patients Who Have Undergone Bilateral Mastectomy

NCT07218874Not ApplicableCompleted

Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application

NCT07175376Not ApplicableRecruiting

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

NCT07677436Not ApplicableNot Yet Recruiting

Effect of Virtual Reality-Guided Imagery on Pain, Anxiety, and Fatigue in Cancer Patients Undergoing Chemotherapy

NCT07663396Not ApplicableNot Yet Recruiting

Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Early-stage Cancer

NCT07435597Not ApplicableCompleted

Comparing the Effects of Art Therapy and Mandala Application on State Anxiety Levels in Chemotherapy Patients

NCT07339488Phase 2Recruiting

Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma

NCT07061236Not ApplicableCompleted

Education Effect on Comfort and Anxiety in 5-FU Elastomeric Pump Therapy

NCT04113226Phase 2CompletedPrimary

Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma

NCT07644533Not ApplicableNot Yet Recruiting

Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Advanced Cancer

NCT05856656Not ApplicableCompleted

Music Therapy as a Tool for Anxiety Reduction in Localized Breast Cancer

NCT07269340Not ApplicableCompleted

Mandala Painting During Chemotherapy

NCT03722121Completed

Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?

NCT06758830Phase 2Recruiting

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

NCT05941741Phase 3Recruiting

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

NCT06271356Not ApplicableCompleted

Breast Cancer - Navigate - Prospective Cohort

Scroll to load more

Research Network

Activity Timeline